Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver mitochondria are specialized double-membrane-bound organelles within hepatocytes that serve as the central hub for energy production and metabolic integration. They are uniquely responsible for critical hepatic functions such as the urea cycle, gluconeogenesis, and the synthesis of ketone bodies, alongside universal roles in the citric acid cycle and oxidative phosphorylation (Grattagliano et al., 2012). In the context of pharmacology, these organelles are frequent sites of drug-induced liver injury (DILI), where xenobiotics can cause oxidative stress, inhibit the electron transport chain, or trigger the mitochondrial permeability transition pore (Pessayre et al., 2012). Conversely, they are therapeutic targets for metabolic modulators like metformin, which exerts its glucose-lowering effects partly through the mild inhibition of mitochondrial Complex I (LiverTox, 2023). Because the term refers to an entire organelle containing thousands of distinct proteins, it is classified as a cellular compartment rather than a single molecular target. Understanding liver mitochondrial health is essential for assessing metabolic disorders and predicting potential hepatotoxicity during drug development.
Modulation of the electron transport chain, uncoupling of oxidative phosphorylation, inhibition of fatty acid beta-oxidation, and regulation of the mitochondrial permeability transition pore (mPTP).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver mitochondrion.